Answers are grounded in this paper and cite their sources.
E,E-Farnesol was transformed into ω-bromo-farnesal, which cyclized to afford a racemic germacrane-type compound (5) with a low-valent chromium reagent 5 was then converted to (±)-dihydrocostunolide and (±)-costunolide.
No takes yet. Share an insight, caveat, or question.
Shibuya et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: